Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05355974 · ClinicalTrials.gov registry record · Phase 3
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
A Phase 3 study, sponsored by Wright State University.
- Completed
- Registry status
- Phase 3
- Development phase
- 42
- Enrollment target
NCT05355974 is a Phase 3 study that has completed, run by Wright State University. The registered enrollment target is 42 participants.
The verdict
NCT05355974, a Phase 3 study, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation will prevent substantial decreases in blood pressure when compared to normal intravenous fluids.
Interventions
- DRUG Norepinephrine
- DRUG normal saline
- DRUG Lactated Ringers, Intravenous
- DRUG Plasma-lyte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2024-07-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05355974
The ClinicalTrials.gov registry entry for NCT05355974 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Norepinephrine is the first listed.
NCT05355974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05355974 about?
NCT05355974 is a clinical study titled "Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure". The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation wil...
What is the current status of trial NCT05355974?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 42 participants. The study started on 2022-08-09. Estimated completion is 2024-07-10.
What interventions are being tested in trial NCT05355974?
The interventions under investigation include: Norepinephrine (DRUG), normal saline (DRUG), Lactated Ringers, Intravenous (DRUG), Plasma-lyte (DRUG).
Who is sponsoring clinical trial NCT05355974?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.